33 research outputs found
The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment – results from an observational study in Germany
WHAT DO HEALTH ECONOMISTS EXPECT FROM THEIR EMPLOYER-RESULTS FROM AN ON-LINE SURVEY IN GERMANY
Hospitalization rates and therapy costs of German Schizophrenia patients who are initiated on long acting injectable medication
P.392 Hospitalization rates and therapy costs of German schizophrenia patients who are initiated on long acting injectable medication
Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
Patents and performance in the Japanese pharmaceutical industry: An institution-based view
Pharmaceutical industry, Japan, Patents, Strategy, Performance, Institutions,